Comparative Analysis of Tirzepatide and Semaglutide for Managing Obesity, Glycemic Control, and Cardiovascular Outcomes: A Review of Clinical Evidence - Top-Institutions - MDSpire

Comparative Analysis of Tirzepatide and Semaglutide for Managing Obesity, Glycemic Control, and Cardiovascular Outcomes: A Review of Clinical Evidence

  • By

  • Maan H. Harbi

  • Ahmad M. Ashour

  • Nasser M. Alorfi

  • Mohammed M. Aldurdunji

  • Saad M. Wali

  • Yahya A. Alzahrani

  • April 22, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School / Massachusetts General Hospital
    Harvard Medical School / Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Cardiovascular Medicine

  • #2

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Endocrinology
    • Metabolic Research
    • Clinical Trials

  • #3

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Obesity Medicine
    • Cardiometabolic Research

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Diabetes Care
    • Cardiovascular Research

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Diabetes Research
    • Cardiovascular Medicine

Original Source(s)

Comparative Analysis of Tirzepatide and Semaglutide for Managing Obesity, Glycemic Control, and Cardiovascular Outcomes: A Review of Clinical Evidence

  • by Maan H. Harbi, Ahmad M. Ashour, Nasser M. Alorfi, Mohammed M. Aldurdunji, Saad M. Wali, Yahya A. Alzahrani

  • April 22, 2026

Related Content

Meta-inflammation in Hidradenitis suppurativa: from pathogenic evidence to therapeutic approaches

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care